Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
about
Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosisSuppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation.Young-onset dementiaInsertion of mutant proteolipid protein results in missorting of myelin proteins.Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 novel PLP1 mutations.Altered PLP1 splicing causes hypomyelination of early myelinating structures.Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.Glial cells: old cells with new twistsNeuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.The myelin proteolipid DMα in fishes.Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.Demyelinating prenatal and infantile developmental neuropathies.Advances in the diagnosis of leukoencephalopathies.Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.Pelizaeus-merzbacher disease: the first genetically approved case report from iran.PLP1 gene analysis in 88 patients with leukodystrophy.Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease.Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS.
P2860
Q27012075-EBFBBC76-C692-4F25-A5B0-BBF72D5BCF5AQ33315713-33608D23-80DD-4A5D-8EC9-59C0143F3F89Q33368845-8397F033-C10F-4519-B4BB-B1B8D7E50B4FQ33660849-ADFA9DED-0C29-4B87-8BFF-A30EFB8387E8Q34955982-27D09F67-B4E3-4F6A-9304-A1A08FEE6353Q35074267-E15BA240-40C3-48BD-A939-6907930BCB28Q35777267-2132FD69-2804-4174-82DE-5C28AB693A48Q36507183-DFA5647D-93A7-4E2C-8331-079AF4671EA5Q37027769-ED5A0BF2-42D8-4911-A3B7-142F0FD46C73Q37423081-62D2C47D-8EB5-4330-AF50-A798C7ED613EQ37512537-B86816C7-913F-4792-9591-FF038653125EQ37649702-201686F1-8606-454E-B052-D345B1C8735EQ37998518-EE079C79-D297-46A4-BEA7-344CC22DF7EAQ38088395-3D7A6B05-2FF9-4458-AF2F-E62705EFD8A4Q40515513-0E6BBDF8-68AB-4DD0-98DF-D0E0DD11D5C7Q42163182-DC01C1E9-1F2D-4888-A45C-5EA2E6422110Q43519758-D616446A-1C4D-47C3-88DD-529F54C854BCQ45732608-7EAE17BF-6609-4F95-AB2B-BC42BB6445BFQ55560238-EB2B2FED-2211-424C-9D0A-9528464EBC6C
P2860
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
@ast
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
@en
type
label
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
@ast
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
@en
prefLabel
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
@ast
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
@en
P2093
P2860
P356
P1433
P1476
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
@en
P2093
Diana Rodriguez
Grace Hobson
James Garbern
John Kamholz
Karen Krajewski
Karen Sperle
Manisha Jain
Odile Boespflug-Tanguy
Pedro Mancias
P2860
P304
P356
10.1002/ANA.10466
P577
2003-03-01T00:00:00Z